Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €40.40 | €82.93 | 105.275% |
| Heron Therapeutics Inc. | 8 | 2 | 3 | 1 | €2.37 | €4.57 | 92.662% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.14 | €10.05 | 143.085% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €78.12 | €102.62 | 31.361% |
| Incyte Corp. | 12 | 2 | 3 | 1 | €49.50 | €78.42 | 58.429% |
| Pfizer Inc. | 31 | 4 | 3 | 1 | €25.83 | €41.10 | 59.129% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €140.00 | €228.30 | 63.071% |
| Staar Surgical Co. | 11 | 1 | 3 | 0 | €42.43 | €49.02 | 15.526% |
| United Therapeutics | 18 | 0 | 3 | 0 | €240.90 | €288.66 | 19.826% |
| CONMED Corp. | 11 | 1 | 3 | 0 | €62.50 | €109.59 | 75.336% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.20 | €20.00 | 40.845% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €23.00 | €68.78 | 199.040% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | €372.90 | €382.71 | 2.629% |
| Align Technology | 15 | 2 | 4 | 0 | €267.20 | €345.95 | 29.472% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €23.39 | €35.43 | 51.472% |
| Sutro Biopharma Inc | 18 | 0 | 4 | 0 | €3.16 | €11.05 | 249.633% |
| Biogen Inc. | 44 | 2 | 4 | 1 | €198.80 | €293.57 | 47.672% |
| Intuitive Surgical Inc | 34 | 0 | 4 | 0 | €352.15 | €370.00 | 5.069% |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €98.76 | €116.81 | 18.274% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.92 | €174.43 | 16.351% |
| Geron Corp. | 12 | 0 | 4 | 0 | €3.68 | €4.63 | 25.769% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €60.91 | €86.77 | 42.458% |
| Centene Corp. | 15 | 0 | 5 | 0 | €69.30 | €82.57 | 19.149% |
| Merit Medical Systems | 16 | 0 | 5 | 0 | €69.50 | €86.90 | 25.032% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.30 | €28.06 | 83.404% |